483 Valeant Pharmaceuticals International Feb 2015

483 Valeant Pharmaceuticals International Feb 2015

Russell Riley FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmaceuticals International - Laval, Canada facility and issued 1 inspectional observation (via FDA 483) on 20 Feb 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 20 Feb 2015
  • Location: Laval, Canada
  • FEI: 3002807186
Add To Cart